Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults
Authors:
- Miguel-Angel PeralesMPMiguel-Angel Perales
- Michael J. MartensMMMichael J. Martens
- Roy F. ChemalyRCRoy F. Chemaly
- Christopher E. DandoyCDChristopher E. Dandoy
- Joshua A. HillJHJoshua A. Hill
- Miguel Angel DiazMDMiguel Angel Diaz
- Shahrukh HashmiSHShahrukh Hashmi
- Susan ProckopSPSusan Prockop
- Hillard M. LazarusHLHillard M. Lazarus
Open Access
- 10 July 2025
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (14) , 3502-3517
Abstract
Allogeneic hematopoietic cell transplantation (allo-HCT) can provide curative treatment for hematologic malignancies but is associated with prolonged lymphopenia that may contribute to an increased risk of infection and relapse, resulting in decreased survival. We hypothesized that patients with rapid and robust CD4 T- and B-cell recovery have improved survival and decreased treatment-related mortality (TRM). A total of 2089 patients were included who underwent first allo-HCT for acute myeloid leukemia/acute lymphoblastic leukemia/myelodysplastic syndrome from 2008 to 2019 reported to the Center for International Blood and Marrow Transplant Research with available CD4 counts at days 100 and 180. Patients (median age, 51 years [range, 2-75]) were categorized into 4 groups based on graft-versus-host disease (GVHD) prophylaxis: ex vivo T-cell depletion (TCD/CD34), posttransplant cyclophosphamide, calcineurin inhibitor alone (CNI), or CNI with antithymocyte globulin. Based upon survival, we could identify optimal cutoff points for CD4+ T cells in pediatric (age of 20 years) patients: 104 × 106/L and 115 × 106/L at days 100 and 180, respectively. In adults, day-100 CD4 count was associated with overall survival (OS), progression-free survival (PFS), and TRM but not relapse, incidence of infections, or chronic GVHD. Similarly, CD4 counts above the cutoff point at day 180 in adults were associated with improved OS, PFS, and TRM but no other outcomes. No clinical associations for CD4 counts were identifiable in pediatric patients. These findings underscore the importance of tailoring transplant strategies for adults to optimize immune recovery and improve patient outcomes.Keywords
This publication has 50 references indexed in Scilit:
- Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysisCytotherapy, 2023
- Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the LevelsTransplantation and Cellular Therapy, 2019
- Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2019
- Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantationJournal of Allergy and Clinical Immunology, 2017
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Immune Recovery in Adult Patients after Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012
- T Cell–Depleted Unrelated Donor Stem Cell Transplantation Provides Favorable Disease-Free Survival for Adults with Hematologic MalignanciesTransplantation and Cellular Therapy, 2011
- Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell countsAmerican Journal of Hematology, 1997
- Serum immunoglobulin levels following allogeneic bone marrow transplantationAnnals of Hematology, 1985